90 results found.
1. |
Ordering Recommendation:
Predict risk of dose-related toxicity and responsiveness to 5-FU therapy. |
|
2. |
Ordering Recommendation:
Do not use to screen for celiac disease. May be used to estimate severity of intestinal villous atrophy in confirmed celiac disease. |
|
3. |
Ordering Recommendation:
May be helpful in evaluating for autoimmune liver disease. For a more comprehensive reflex panel, refer to Autoimmune Liver Disease Evaluation with Reflex to Smooth Muscle Antibody (SMA), IgG by IFA (2007210). |
|
4. |
Ordering Recommendation:
Aid in evaluation of autoimmune liver disease. For a more comprehensive reflex panel, refer to Autoimmune Liver Disease Evaluation with Reflex to Smooth Muscle Antibody (SMA), IgG by IFA (2007210). |
|
5. |
Ordering Recommendation:
Evaluate for possible factor II deficiency. For prothrombin variant testing (inherited thrombotic risk factor), order Prothrombin (F2) c.*97G>A (G20210A) Pathogenic Variant (0056060). |
|
6. |
Ordering Recommendation:
Order to diagnose factor IX deficiency, detect factor IX inhibitors, and monitor factor IX replacement therapy. |
|
7. |
Ordering Recommendation:
Order to diagnose factor IX deficiency (hemophilia B) and monitor factor IX replacement therapy. |
|
8. |
Ordering Recommendation:
Order to detect factor V Leiden variant. |
|
9. | ||
10. |
Ordering Recommendation:
Determine thrombotic risk in individuals known to be factor V Leiden heterozygotes. |
|
11. |
Ordering Recommendation:
Evaluate possible factor VII deficiency. |
|
12. |
Ordering Recommendation:
Order to diagnose factor VIII deficiency, detect factor VIII inhibitors, and monitor factor VIII replacement therapy. |
|
13. |
Ordering Recommendation:
Order to diagnose hemophilia A, acquired factor VIII deficiency, or as part of a diagnostic workup for von Willebrand disease. Not recommended when screening for thrombophilia. |
|
14. |
Ordering Recommendation:
Evaluate possible factor X deficiency. |
|
15. |
Ordering Recommendation:
Order to diagnose factor XI deficiency (hemophilia C). |
|
16. |
Ordering Recommendation:
Evaluate the cause of an isolated prolonged PTT in a patient who is not currently bleeding. |
|
17. |
Ordering Recommendation:
Assess genetic risk for thrombosis. |
|
18. |
Ordering Recommendation:
First-line test to diagnose FXIII deficiency. Appropriate for evaluation of patients with a bleeding disorder presenting with normal PT, aPTT, and platelet count test results. Monitor FXIII therapy and confirm abnormalities detected on FXIII qualitative assay. |
|
19. |
Ordering Recommendation:
Most useful for acquired or severe FXIII deficiency testing. Abnormal results should be confirmed with quantitative testing. Refer to Factor XIII Activity (2006182). |
|
20. |
Ordering Recommendation:
Refer to ARUP Immunohistochemistry Stain Offerings brochure at www.aruplab.com/ap/resources. |
|
21. |
Ordering Recommendation:
Acceptable diagnostic or predictive test for familial adenomatous polyposis. For classic FAP, consider Familial Adenomatous Polyposis Panel: (APC) Sequencing and Deletion/Duplication, (MUTYH) 2 Mutations (2004915). |
|
22. |
Familial Adenomatous Polyposis Panel: (APC) Sequencing and Deletion/Duplication, (MUTYH) 2 Mutations
Ordering Recommendation:
Preferred diagnostic or predictive test for familial adenomatous polyposis and MUTYH-associated polyposis. |
|
23. |
Ordering Recommendation:
Preferred test when clinical symptoms are suspicious for familial Mediterranean fever. |
|
24. |
Ordering Recommendation:
Recommended test for a known familial sequence variant previously identified in a family member. A copy of the family member’s test result documenting the familial variant is required. Consultation with a genetic counselor is advised. |
|
25. |
Ordering Recommendation:
Consultation with a genetic counselor is advised. Order for fetal testing to detect a previously characterized variant in a family member. |
|
26. |
Ordering Recommendation:
Confirm a clinical diagnosis of familial transthyretin (TTR) amyloidosis, familial euthyroid hyperthyroxinemia, or senile systemic amyloidosis. |
|
27. |
Ordering Recommendation:
Carrier screening or diagnostic testing for Fanconi anemia group C for individuals of Ashkenazi Jewish descent. |
|
28. |
|
|
29. |
|
|
30. |
Ordering Recommendation:
Measurement of fecal fats can be useful in establishing a diagnosis of pancreatic disease. Testing requires the submission of an entire 24-hour stool collection. |
|
31. |
Ordering Recommendation:
Measurement of fecal fats can be useful in establishing a diagnosis of pancreatic disease. Testing requires the submission of an entire 48-hour stool collection. |
|
32. |
Ordering Recommendation:
Measurement of fecal fats can be useful in establishing a diagnosis of pancreatic disease. Testing requires the submission of an entire 72-hour stool collection. |
|
33. |
Ordering Recommendation:
Measurement of fecal fats can be useful in establishing a diagnosis of pancreatic disease. Testing requires the submission of an aliquot from a 24-, 48-, or 72-hour stool collection. |
|
34. |
|
|
35. |
Ordering Recommendation:
Identification of patients with essential fatty acid deficiency, evaluation of nutritional status, and diet monitoring. |
|
36. |
|
|
37. |
Ordering Recommendation:
Confirm presence of disease; not recommended for initial testing. |
|
38. |
Ordering Recommendation:
Optimize drug therapy and monitor patient adherence. |
|
39. |
Ordering Recommendation:
Useful for general screening in contexts of compliance and/or abuse. A screen with reflex testing is the preferred method for ruling out amphetamine exposure. For follow-up testing of a presumptive result, Fentanyl and Metabolite, Urine Quantitative (0092570) is preferred. |
|
40. |
Ordering Recommendation:
Monitor patient adherence. |
|
41. |
Ordering Recommendation:
Preferred test to follow-up presumptive results. For general screening, Fentanyl, Urine Screen with Reflex to Quantitation (2012284) is preferred. |
|
42. |
Ordering Recommendation:
Aid in the diagnosis of iron deficiency anemia and iron overload. Monitor treatment of hemochromatosis. |
|
43. |
Ordering Recommendation:
Assess risk of preterm delivery in less than or equal to 7-14 days from time of sample collection at 24 weeks 0 days to 34 weeks 6 days gestation when there are signs and symptoms of early preterm labor. |
|
44. |
Ordering Recommendation:
Detect and quantify the extent of fetomaternal hemorrhage in pregnant or postpartum women. Assess the need for Rh immunoglobulin (eg, RhoGAM) for fetomaternal hemorrhage. |
|
45. |
|
|
46. |
Ordering Recommendation:
Recommended for the diagnosis of systemic sclerosis in patients negative for centromere, Scl-70, or RNA polymerase III antibodies. May predict skeletal muscle involvement and pulmonary arterial hypertension. |
|
47. |
Ordering Recommendation:
May be useful for the evaluation of rare disorders such as primary fibrinolysis. For evaluating coagulopathies (eg, disseminated intravascular coagulation), D-Dimer (0030057) is the preferred test. |
|
48. |
Ordering Recommendation:
Determine if fibrinogen deficiency is a potential cause of bleeding. |
|
49. |
Ordering Recommendation:
A follow-up test for decreased fibrinogen activity to determine if the decrease is due to insufficient fibrinogen or dysfunctional fibrinogen. |
|
50. |
Ordering Recommendation:
Assist in diagnosing dysfibrinogenemia. |
|
51. |
|
|
52. |
Ordering Recommendation:
Confirm diagnosis of ichthyosis vulgaris and differentiate vulgaris from other forms of ichthyosis. |
|
53. |
Ordering Recommendation:
Aid in the detection of antibodies to filaria. Consider Parasites Smear (Giemsa Stain), Blood (0049025). |
|
54. |
Ordering Recommendation:
Optimize drug therapy and monitor patient adherence. |
|
55. |
Ordering Recommendation:
Aid in the diagnosis and management of acute myeloid leukemia. |
|
56. |
Ordering Recommendation:
Optimize drug therapy and monitor patient adherence. |
|
57. |
Ordering Recommendation:
Detect exposure. |
|
58. |
Ordering Recommendation:
Detect exposure. |
|
59. |
|
|
60. |
Ordering Recommendation:
Screening culture for fluoroquinolone-resistant organisms. Consider prior to trans-rectal prostate biopsy. |
|
61. |
Ordering Recommendation:
Optimize drug therapy and monitor patient adherence. |
|
62. |
Ordering Recommendation:
Optimize drug therapy and monitor patient adherence. |
|
63. |
|
|
64. |
Ordering Recommendation:
Aids in detection of folate deficiency. |
|
65. |
Ordering Recommendation:
Aids in detection of folate deficiency. |
|
66. |
|
|
67. |
|
|
68. |
|
|
69. |
Ordering Recommendation:
Use in conjunction with histologic and clinical information for the diagnosis of alveolar rhabdomyosarcoma. |
|
70. |
Ordering Recommendation:
Preferred test to diagnose fragile X syndrome and carrier screening in individuals with a positive family history. |
|
71. |
Ordering Recommendation:
Prenatal test for fetuses of mothers with fragile X premutations or full mutations. |
|
72. |
Ordering Recommendation:
Preferred test for detecting antibodies during acute or convalescent phase. Convalescent sera may be required for diagnosis. |
|
73. |
Ordering Recommendation:
Detects antibodies during convalescent phase. Convalescent sera may be required for diagnosis. |
|
74. |
Ordering Recommendation:
Detects antibodies during acute phase; paired concurrent specimen with IgG reduces false positive rate. Convalescent sera may be required for diagnosis. |
|
75. |
Ordering Recommendation:
Direct measure of free estradiol in serum. Most accurate measure of bioactive estradiol. |
|
76. |
Ordering Recommendation:
Diagnostic testing for Freeman-Sheldon syndrome. |
|
77. |
Ordering Recommendation:
May aid in monitoring glucose control for diabetes in specific disorders. Not recommended as a substitute for hemoglobin A1c except in specific populations. |
|
78. |
Ordering Recommendation:
Useful when screening for obstruction or absence of the seminal vesicles in males with azoospermia. |
|
79. |
Ordering Recommendation:
Refer to ARUP Immunohistochemistry Stain Offerings brochure at www.aruplab.com/ap/resources. |
|
80. |
Ordering Recommendation:
Identify fungi from culture. |
|
81. |
Ordering Recommendation:
Not recommended. Refer to individual fungus-related tests appropriate to patient exposure. |
|
82. |
Ordering Recommendation:
Not recommended. Refer to individual fungal antibody tests, as relevant to patient exposure(s). |
|
83. |
Ordering Recommendation:
Not recommended for the diagnosis of fungal infection of the central nervous system. Refer to individual fungal antibody tests, as relevant to patient exposure(s). |
|
84. |
Ordering Recommendation:
Gold standard test to diagnose fungi as agent of infection. |
|
85. |
Ordering Recommendation:
Identify fungi from culture. |
|
86. |
Ordering Recommendation:
Identify fungus using fungal smear (eg, yeast, aseptate hyphae, septate hyphae). |
|
87. |
|
|
88. |
Ordering Recommendation:
Use in conjunction with histologic evaluation. Positive FUS rearrangement may support the diagnosis of low-grade fibromyxoid sarcoma (LGFMS). |
|
89. |
Ordering Recommendation:
Determine if the Fy(a) (FY1) antigen is expressed on the patient's red blood cells. To determine if the patient is heterozygous or homozygous for the Fy(a) antigen, FYB Antigen Typing - Patient (2007725) should also be ordered. |
|
90. |
Ordering Recommendation:
Determine if the Fy(b) (FY2) antigen is expressed on the patient's red blood cells. To determine if the patient is heterozygous or homozygous for the Fy(b) antigen, FYA Antigen Typing - Patient (2007717) should also be ordered. |